Insulin, Globin Zinc
Showing 1 - 25 of 8,892
Diabetes Trial in Lancaster (Zinc acetate)
Completed
- Diabetes
- Zinc acetate
-
Lancaster, PennsylvaniaAmish Research Clinic
Jan 4, 2022
Obesity, Childhood, Insulin Resistance, Zinc Deficiency Trial in Novara (Zinc, Placebos, Myoinositol)
Recruiting
- Obesity, Childhood
- +3 more
- Zinc
- +2 more
-
Novara, ItalyAOU Maggiore della Carità - Clinica Pediatrica - Ambulatorio di
Mar 4, 2022
Insulin Pump,Continuous Glucose Monitoring Technology Trial in Guandong (Insulin Glargine, Metformin, Dapagliflozin)
Recruiting
- Insulin Pump，Continuous Glucose Monitoring Technology
- Insulin Glargine
- +3 more
-
Guandong, China刘烈华
Nov 7, 2023
Scars, Insulin Trial in Alexandria (Microneedling with topical application of regular insulin, Microneedling with topical
Recruiting
- Scars
- Insulin
- Microneedling with topical application of regular insulin
- Microneedling with topical application of saline
-
Alexandria, EgyptAlexandria University, Faculty of Medicine
Sep 7, 2023
Smell Dysfunction, Taste Disorders, Taste Disorder, Secondary, Sweet Trial (Insulin aspart)
Not yet recruiting
- Smell Dysfunction
- +4 more
- Insulin aspart
- (no location specified)
Oct 30, 2021
ATROPHIC ACNE SCARS Trial in Karachi (PRP( platelet rich plasma) and Insulin human)
Completed
- ATROPHIC ACNE SCARS
- PRP( platelet rich plasma) and Insulin human
-
Karachi, Sindh, PakistanJPMC
Aug 18, 2023
Alcohol Use Disorder Trial (Regular Human Insulin then Placebo, Placebo then Regular Human Insulin)
Not yet recruiting
- Alcohol Use Disorder
- Regular Human Insulin then Placebo
- Placebo then Regular Human Insulin
- (no location specified)
Aug 9, 2023
Healthy Trial in Saint Paul (Low dose Regular Insulin, High dose Regular insulin)
Recruiting
- Healthy
- Low dose Regular Insulin
- High dose Regular insulin
-
Saint Paul, MinnesotaHealthPartners Neuroscience Center
May 23, 2023
Type 1 Diabetes Trial in Bobo-Dioulasso, Ouagadougou (premix insulin human isophane suspension and insulin human, Humulin N plus
Not yet recruiting
- Type 1 Diabetes
- premix insulin human isophane suspension and insulin human
- Humulin N plus Humulin R
-
Bobo-Dioulasso, Houet, Burkina Faso
- +2 more
Mar 12, 2023
Type 2 Diabetes Trial in South Miami (Insulin Glargine, Insulin Aspart, Insulin Lispro)
Terminated
- Type 2 Diabetes Mellitus
- Insulin Glargine
- +2 more
-
South Miami, FloridaUniversity of Miami
Aug 18, 2022
Type2diabetes Trial in Nanning (Henagliflozin, Continuous Subcutaneous Insulin Infusion)
Not yet recruiting
- Type2diabetes
- Henagliflozin
- Continuous Subcutaneous Insulin Infusion
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Jan 9, 2023
Double Diabetes Trial in Dijon (Insulin + semaglutide treatment, Usual insulin treatment, Biological check-up)
Recruiting
- Double Diabetes
- Insulin + semaglutide treatment
- +2 more
-
Dijon, FranceChu Dijon Bourgogne
Jul 18, 2022
UVB Phototherapy Burn, Insulin-like Growth Factor 1, Aging Trial in Fairborn (Insulin-Like Growth Factor 1, No Insulin-Lie
Recruiting
- UVB Phototherapy Burn
- +2 more
- Insulin-Like Growth Factor 1
- No Insulin-Lie Growth Factor 1
-
Fairborn, OhioWright State Physicians
Jan 9, 2023
Intraoperative Complications Trial in Cairo (Rapid-Acting Insulin)
Completed
- Intraoperative Complications
- Rapid-Acting Insulin
-
Cairo, EgyptAin-Shams University
Oct 24, 2022
Type 2 Diabetes Trial in Chengdu (Insulin degludec injection, RD15003, Insulin degludec, Tresiba)
Completed
- Type 2 Diabetes
- Insulin degludec injection, RD15003
- Insulin degludec, Tresiba
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Oct 7, 2022
Type 2 Diabetes Trial in Nanjing (Tirzepatide, Insulin Glargine)
Recruiting
- Type 2 Diabetes Mellitus
- Tirzepatide
- Insulin Glargine
-
Nanjing, Jiangsu, ChinaNanjing First Hospital
Sep 21, 2022
Diabetes, Type 1 Trial (Afrezza, insulin degludec, Rapid-acting Insulin Analog)
Not yet recruiting
- Diabetes Mellitus, Type 1
- Afrezza
- +3 more
- (no location specified)
Jun 6, 2023
Diabetes, Pregnancy Complications Trial in Copenhagen (Faster-acting Aspart insulin Fiasp, Control (insulin Novorapid))
Active, not recruiting
- Diabetes Mellitus
- Pregnancy Complications
- Faster-acting Aspart insulin Fiasp
- Control (insulin Novorapid)
-
Copenhagen, DenmarkCenter for Pregnant Women with Diabetes, Rigshospitalet
Oct 25, 2022
Type 2 Diabetes Trial in Changsha (metformin+empagliflozin+insulin glargine, IDegLira, premixed insulin analogues)
Recruiting
- Type 2 Diabetes Mellitus
- metformin+empagliflozin+insulin glargine
- +2 more
-
Changsha, Hunan, ChinaXiangya Hospital of Central South University
Sep 15, 2022
Nonalcoholic Steatohepatitis (NASH) Trial in Gent (ORMD-0801 QD, ORMD-0801 BD)
Completed
- Nonalcoholic Steatohepatitis (NASH)
- ORMD-0801 QD
- ORMD-0801 BD
-
Gent, BelgiumUniversitaire Ziekenhuis Gent
Sep 15, 2022
type1diabetes, Diabetes, Type 1 Trial in Montreal (Pramlintide, Insulin Lispro, Insulin aspart)
Not yet recruiting
- type1diabetes
- Diabetes Mellitus, Type 1
- Pramlintide
- +3 more
-
Montreal, Quebec, CanadaResearch Institute of the McGill University Health Center
Sep 18, 2023
Type 1 Diabetes, Diabetes, Type 1 Trial in Australia (Abatacept (CTLA4-Ig) and nasal insulin (Humulin R®), Abatacept (CTLA4-Ig)
Recruiting
- Type 1 Diabetes
- Diabetes Mellitus, Type 1
- Abatacept (CTLA4-Ig) and nasal insulin (Humulin R®)
- Abatacept (CTLA4-Ig) and nasal placebo (0.9% sodium chloride)
-
Westmead, New South Wales, Australia
- +5 more
Feb 15, 2023
Glucose, High Blood Trial in Palm Beach Gardens (Human Insulin, Finger-actuated, Metered Pump Sprayer)
Not yet recruiting
- Glucose, High Blood
- Human Insulin
- Finger-actuated, Metered Pump Sprayer
-
Palm Beach Gardens, FloridaLangford Research Institute
Aug 3, 2022
Cystic Fibrosis Trial in Minneapolis, Saint Paul (novolog insulin, levemir insulin, )
Completed
- Cystic Fibrosis
- novolog insulin
- +2 more
-
Minneapolis, Minnesota
- +1 more
Aug 8, 2022